Postnatal modulation of body composition in preterm infants by human growth factors and hormones in relation to various nutrient compositions.
- Conditions
- hypertensiecardiovascular diseases/heart diseaserisk factors for diabetes mellitus/diabetes1001842410013317
- Registration Number
- NL-OMON47744
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 170
1. Written and informed consent from either the parents or the legal guardians who at least have professional working proficiency of the Dutch, English or French language.
2. Gestational age of 24 to 32 weeks.
3. Arterial catheter in situ.;In order to be eligible for cord blood analysis, a subject must meet all of the following criteria:
1. Gestational age of 24 to 42 weeks
2. Written and informed consent from either the parents or the legal guardians who at least have professional working proficiency of the Dutch, English or French language.
A substantial congenital anomaly based on a chromosomal or syndromal disorder with a known effect on growth and body composition.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study parameters are anthropometry (height, weight and body<br /><br>proportions), body composition and growth-related endocrine parameters.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Psychomotor development, bone mineralization, lipid status and blood pressure</p><br>